1. Home
  2. ITRM vs NTIP Comparison

ITRM vs NTIP Comparison

Compare ITRM & NTIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITRM
  • NTIP
  • Stock Information
  • Founded
  • ITRM 2015
  • NTIP 1990
  • Country
  • ITRM Ireland
  • NTIP United States
  • Employees
  • ITRM N/A
  • NTIP N/A
  • Industry
  • ITRM Biotechnology: Pharmaceutical Preparations
  • NTIP Multi-Sector Companies
  • Sector
  • ITRM Health Care
  • NTIP Miscellaneous
  • Exchange
  • ITRM Nasdaq
  • NTIP Nasdaq
  • Market Cap
  • ITRM 24.7M
  • NTIP 29.5M
  • IPO Year
  • ITRM 2018
  • NTIP 1998
  • Fundamental
  • Price
  • ITRM $1.37
  • NTIP $1.33
  • Analyst Decision
  • ITRM Strong Buy
  • NTIP
  • Analyst Count
  • ITRM 1
  • NTIP 0
  • Target Price
  • ITRM $5.00
  • NTIP N/A
  • AVG Volume (30 Days)
  • ITRM 7.1M
  • NTIP 49.6K
  • Earning Date
  • ITRM 11-14-2024
  • NTIP 10-24-2024
  • Dividend Yield
  • ITRM N/A
  • NTIP 7.41%
  • EPS Growth
  • ITRM N/A
  • NTIP N/A
  • EPS
  • ITRM N/A
  • NTIP N/A
  • Revenue
  • ITRM N/A
  • NTIP $1,881,000.00
  • Revenue This Year
  • ITRM N/A
  • NTIP N/A
  • Revenue Next Year
  • ITRM N/A
  • NTIP N/A
  • P/E Ratio
  • ITRM N/A
  • NTIP N/A
  • Revenue Growth
  • ITRM N/A
  • NTIP 129.39
  • 52 Week Low
  • ITRM $0.81
  • NTIP $1.24
  • 52 Week High
  • ITRM $2.50
  • NTIP $2.25
  • Technical
  • Relative Strength Index (RSI)
  • ITRM 54.25
  • NTIP 50.04
  • Support Level
  • ITRM $1.25
  • NTIP $1.29
  • Resistance Level
  • ITRM $1.61
  • NTIP $1.34
  • Average True Range (ATR)
  • ITRM 0.14
  • NTIP 0.04
  • MACD
  • ITRM 0.00
  • NTIP 0.01
  • Stochastic Oscillator
  • ITRM 46.67
  • NTIP 76.56

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a clinical-stage pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally. Its sulopenem program has the potential to offer a solution to the problem of antibiotic resistance and the toxicity limitations of existing agents. The company operates as a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

About NTIP Network-1 Technologies Inc.

Network-1 Technologies Inc is involved in the business of the development, licensing, and protection of intellectual property rights. The company's current plan includes continuing to pursue licensing opportunities for its intellectual property assets.

Share on Social Networks: